This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,754.00, is for the delivery of Mounjaro 7.5 mg/0.5 ml pens, a prescription medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 4, 2024. AmerisourceBergen, a for-profit organization, is the prime contractor for this award, which is not designated as a set-aside contract. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/4/25, 11:19 AM